Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

Paul Takam Kamga; Aurélie Swalduz; Adrien Costantini; Catherine Julié; Jean-François Emile; Maurice Pérol; Virginie Avrillon; Sandra Ortiz-Cuaran; Pierre De Saintigny; Etienne Giroux-Leprieur

doi:10.3389/fonc.2022.852540

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

Front Oncol. 2022 Feb 9:12:852540. doi: 10.3389/fonc.2022.852540. eCollection 2022.

Authors

Paul Takam Kamga¹, Aurélie Swalduz^{2

3}, Adrien Costantini^{1

4}, Catherine Julié^{1

5}, Jean-François Emile¹, Maurice Pérol², Virginie Avrillon³, Sandra Ortiz-Cuaran³, Pierre De Saintigny^{2

3}, Etienne Giroux-Leprieur^{1

4}

Affiliations

¹ Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France.
² Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
³ Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
⁴ Department of Respiratory Diseases and Thoracic Oncology, APHP - Hopital Ambroise Pare, Boulogne-Billancourt, France.
⁵ Department of Pathology, APHP - Hopital Ambroise Pare, Boulogne-Billancourt, France.

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.747692.].

Keywords: Sonic Hedgehog (Shh); biomarker; epidermal growth factor receptor (EGFR); non-small cell lung cancer (NSCLC); tyrosine kinase inhibitor (TKI).

Publication types

Published Erratum